Skip to search formSkip to main contentSkip to account menu

Pharmacogenomic Testing

Known as: Pharmacogenetic Testings, Pharmacogenomic Testings, Pharmacogenomic Test 
An assay intended to study interindividual variations in whole-genome or candidate gene, single-nucleotide polymorphism (SNP) maps, haplotype markers… 
National Institutes of Health

Related topics

Related topics

4 relations
Pharmacogenetic TestPharmacogenomic Analysislegislation & jurisprudencestandards characteristics

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
[Use of pharmacogenetic testing to prevent adverse drug reactions during statin therapy].
The number of patients receiving statins increases every year and due to the fact that they should take statins during their… 
Review
2014
Review
2014
Pharmacogenetics and Future Therapeutic Scenarios: What Affects the Prediction of Response to Treatment with Etanercept?
Enabling Technology, Genomics, Proteomics Clinical Development Phases I‐III Regulatory, Quality, Manufacturing 
2014
2014
The influence of the CYP2C19*10 allele on clopidogrel activation and CYP2C19*2 genotyping
Background/objectives The polymorphic hepatic enzyme CYP2C19 catalyzes the metabolism of clinically important drugs such as… 
2014
2014
THE RESPONSE TO ATYPICAL ANTIPSYCHOTIC DRUGS IN CORRELATION WITH THE CYP2D6 GENOTYPE: CLINICAL IMPLICATIONS AND PERSPECTIVES
Atypical antipsychotics are widely used and have been shown to be effective against both positive and negative symptoms of… 
2013
2013
Predicting the cost and pace of pharmacogenomic advances: an evidence-based study.
BACKGROUND Adverse outcomes associated with prescription drug use are common and costly. Many adverse outcomes can be avoided… 
Review
2012
Review
2012
Pharmacogenomic update on multiple sclerosis: a focus on actual and new therapeutic strategies
Multiple sclerosis (MS) is an inflammatory and demyelinating disease of central nervous system comprising several subtypes… 
Review
2010
Review
2010
Pharmacogenetic testing in the United Kingdom genetics and immunogenetics laboratories.
AIM For certain drugs, pharmacogenetic tests can reduce adverse drug reactions and improve treatment efficacy. However, the… 
2008
2008
Patient preferences for pharmacogenetic screening in depression
Objectives: The aims of this study were to estimate preferences and willingness-to-pay (WTP) for genetic screening for CYP2D6… 
Review
2007
Review
2007
Thirty-Gene Pharmacogenomic Test Correlates with Residual Cancer Burden after Preoperative Chemotherapy for Breast Cancer
Purpose: We examined whether the response predicted by a 30-gene pharmacogenomic test correlated with the residual cancer burden… 
Review
2006
Review
2006
Genetic Testing in Cancer Therapeutics
A major challenge to physicians administering drugs with a low therapeutic index, such as chemotherapeutic agents, is the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)